• 1
    DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979; 237: E214E223.
  • 2
    Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 1989; 38: 15121527.
  • 3
    Haffner SM, Howard G, Mayer E et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study. Diabetes 1997; 46: 6369.
  • 4
    Buchanan TA, Xiang A, Kjos SL et al. Gestational diabetes: antepartum characteristics that predict postpartum glucose intolerance and type 2 diabetes in Latino women. Diabetes 1998; 47: 13021310.
  • 5
    Wallace TM, Matthews DR. The assessment of insulin resistance in man. Diabet Med 2002; 19: 527534.
  • 6
    Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000; 85: 24022410.
  • 7
    Bergman RN, Hucking K, Watanabe RM. Measuring insulin action in vivo. In: DeFronzo RA, Ferranini E, Keen H, Zimmet P (eds). International Textbook of Diabetes Mellitus, 3rd edn. Wiley: UK, 2004, pp 303318.
  • 8
    Hoffman RP. Indices of insulin action calculated from fasting glucose and insulin reflect hepatic, not peripheral, insulin sensitivity in African-American and Caucasian adolescents. Pediatr Diabetes 2008; 9: 5761.
  • 9
    Bergman RN, Zaccaro DJ, Watanabe RM et al. Minimal model-based insulin sensitivity has greater heritability and a different genetic basis than homeostasis model assessment or fasting insulin. Diabetes 2003; 52: 21682174.
  • 10
    Katsuki A, Sumida Y, Urakawa H et al. Neither homeostasis model assessment nor quantitative insulin sensitivity check index can predict insulin resistance in elderly patients with poorly controlled type 2 diabetes mellitus. J Clin Endocrinol Metab 2002; 87: 53325335.
  • 11
    Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001; 24: 539548.
  • 12
    Cederholm J, Wibell L. Insulin release and peripheral sensitivity at the oral glucose tolerance test. Diabetes Res Clin Pract 1999; 10: 167175.
  • 13
    Gutt M, Davis CL, Spitzer SB et al. Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures. Diabetes Res Clin Pract 2000; 47: 177184.
  • 14
    Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 14621470.
  • 15
    Soonthornpun S, Setasuban W, Thamprasit A et al. Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 2003; 88: 10191023.
  • 16
    Horowitz M, Edelbroek MA, Wishart JM, Straathof JW. Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects. Diabetologia 1993; 36: 857862.
  • 17
    Bergman RN, Watanabe R, Rebrin K, Ader M, Steil G. Toward an integrated phenotype in pre-NIDDM. Diabet Med 1996; 13 (9 Suppl 6): S67S77.
  • 18
    Ni TC, Ader M, Bergman RN. Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption. Diabetes 1997; 46: 18131821.
  • 19
    Watanabe RM, Bergman RN. Accurate measurement of endogenous insulin secretion does not require separate assessment of C-peptide kinetics. Diabetes 2000; 49: 373382.
  • 20
    Cobelli C, Toffolo G, Ferrannini E. A model of glucose kinetics and their control by insulin, compartmental and noncompartmental approaches. Math Biosci 1984; 72: 291315.
  • 21
    Watanabe RM, Steil GM, Bergman RN. Critical evaluation of the combined model approach for estimation of pre-hepatic insulin secretion. Am J Physiol 1998; 274: E172E183.
  • 22
    Ferrannini E, Smith JD, Cobelli C et al. Effect of insulin on the distribution and disposition of glucose in man. J Clin Invest 1985; 76: 357364.
  • 23
    Tillil H, Shapiro ET, Miller MA et al. Dose-dependent effects of oral and intravenous glucose on insulin secretion and clearance in normal humans. Am J Physiol 1988; 254: E349E357.
  • 24
    Basu R, Breda E, Oberg AL et al. Mechanisms of the age-associated deterioration in glucose tolerance: contribution of alterations in insulin secretion, action, and clearance. Diabetes 2003; 52: 17381748. Erratum in: Diabetes 2003;52: 3014.
  • 25
    Hardin DS, Leblanc A, Lukenbough S, Seilheimer DK. Insulin resistance is associated with decreased clinical status in cystic fibrosis. J Pediatr 1997; 130: 948956.
  • 26
    Holl RW, Heinze E, Wolf A, Rank M, Teller WM. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis. Eur J Pediatr 1995; 154: 356361.
  • 27
    Ranganath L, Norris F, Morgan L, Wright J, Marks V. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect. Diabet Med 1998; 15: 120124.
  • 28
    Seifarth C, Bergmann J, Holst JJ et al. Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. Diabet Med 1998; 15: 485491.
  • 29
    Fischer S, Patzak A, Rietzsch H et al. Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients. Diabetes Obes Metab 2003; 5: 3844.
  • 30
    Kanauchi M, Tsujimoto N, Hashimoto T. Validation of simple indices to assess insulin sensitivity based on the oral glucose tolerance test in the Japanese population. Diabetes Res Clin Pract 2002; 55: 229235.
  • 31
    Cagnacci A, Arangino S, Renzi A, Cagnacci P, Volpe A. Insulin sensitivity in women: a comparison among values derived from intravenous glucose tolerance tests with different sampling frequency, oral glucose tolerance test or fasting. Eur J Endocrinol 2001; 145: 281287.
  • 32
    Chiu KC, Chuang LM, Yoon C. Comparison of measured and estimated indices of insulin sensitivity and beta cell function: impact of ethnicity on insulin sensitivity and beta cell function in glucose-tolerant and normotensive subjects. J Clin Endocrinol Metab 2001; 86: 16201625.
  • 33
    Albareda M, Rodriguez-Espinosa J, Murugo M, de Leiva A, Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000; 43: 15071511.
  • 34
    Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of beta-cell function: the hyperbolic correction. Diabetes 2002; 51 (Suppl 1):S212S220.
  • 35
    Lombardo F, De Luca F, Rosano M et al. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia. Eur J Endocrinol 2003; 149: 5359.
  • 36
    Hardin DS, Leblanc A, Marshall G, Seilheimer DK. Mechanisms of insulin resistance in cystic fibrosis. Am J Physiol Endocrinol Metab 2001; 281: E1022E1028.